Literature DB >> 25636474

Methods to generate genetically engineered mouse models of soft tissue sarcoma.

Rebecca D Dodd1, Leonor Añó, Jordan M Blum, Zhizhong Li, David Van Mater, David G Kirsch.   

Abstract

We discuss the generation of primary soft tissue sarcomas in mice using the Cre-loxP system to activate conditional mutations in oncogenic Kras and the tumor suppressor p53 (LSL-Kras(G12D/+); p53(flox/flox)). Sarcomas can be generated either by adenoviral delivery of Cre recombinase, activation of transgenic Cre recombinase with tamoxifen, or through transplantation of isolated satellite cells with Cre activation in vitro. Various applications of these models are discussed, including anticancer therapies, metastasis, in vivo imaging, and genetic requirements for tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25636474      PMCID: PMC5612825          DOI: 10.1007/978-1-4939-2297-0_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  A spatially and temporally restricted mouse model of soft tissue sarcoma.

Authors:  David G Kirsch; Daniela M Dinulescu; John B Miller; Jan Grimm; Philip M Santiago; Nathan P Young; G Petur Nielsen; Bradley J Quade; Christopher J Chaber; Christian P Schultz; Osamu Takeuchi; Roderick T Bronson; Denise Crowley; Stanley J Korsmeyer; Sam S Yoon; Francis J Hornicek; Ralph Weissleder; Tyler Jacks
Journal:  Nat Med       Date:  2007-08-05       Impact factor: 53.440

2.  Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle.

Authors:  Richard I Sherwood; Julie L Christensen; Irina M Conboy; Michael J Conboy; Thomas A Rando; Irving L Weissman; Amy J Wagers
Journal:  Cell       Date:  2004-11-12       Impact factor: 41.582

3.  NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.

Authors:  Rebecca D Dodd; Jeffrey K Mito; William C Eward; Rhea Chitalia; Mohit Sachdeva; Yan Ma; Jordi Barretina; Leslie Dodd; David G Kirsch
Journal:  Mol Cancer Ther       Date:  2013-07-15       Impact factor: 6.261

4.  Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells.

Authors:  Jordan M Blum; Leonor Añó; Zhizhong Li; David Van Mater; Brian D Bennett; Mohit Sachdeva; Irina Lagutina; Minsi Zhang; Jeffrey K Mito; Leslie G Dodd; Diana M Cardona; Rebecca D Dodd; Nerissa Williams; Yan Ma; Christoph Lepper; Corinne M Linardic; Sayan Mukherjee; Gerard C Grosveld; Chen-Ming Fan; David G Kirsch
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

5.  Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas.

Authors:  Everett J Moding; Darin P Clark; Yi Qi; Yifan Li; Yan Ma; Ketan Ghaghada; G Allan Johnson; David G Kirsch; Cristian T Badea
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-01       Impact factor: 7.038

Review 6.  Soft tissue sarcomas of adults: state of the translational science.

Authors:  Ernest C Borden; Laurence H Baker; Robert S Bell; Vivien Bramwell; George D Demetri; Burton L Eisenberg; Christopher D M Fletcher; Jonathan A Fletcher; Marc Ladanyi; Paul Meltzer; Brian O'Sullivan; David R Parkinson; Peter W T Pisters; Scott Saxman; Samuel Singer; Murali Sundaram; Allan T van Oosterom; Jaap Verweij; Jill Waalen; Sharon W Weiss; Murray F Brennan
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

7.  Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma.

Authors:  Jeffrey K Mito; Hooney D Min; Yan Ma; Jessica E Carter; Brian E Brigman; Leslie Dodd; David Dankort; Martin McMahon; David G Kirsch
Journal:  J Pathol       Date:  2012-11-20       Impact factor: 7.996

8.  Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements.

Authors:  Christoph Lepper; Simon J Conway; Chen-Ming Fan
Journal:  Nature       Date:  2009-07-30       Impact factor: 49.962

9.  Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging.

Authors:  Jeffrey K Mito; Jorge M Ferrer; Brian E Brigman; Chang-Lung Lee; Rebecca D Dodd; William C Eward; Lisa F Marshall; Kyle C Cuneo; Jessica E Carter; Shalini Ramasunder; Yongbaek Kim; W David Lee; Linda G Griffith; Moungi G Bawendi; David G Kirsch
Journal:  Cancer       Date:  2012-03-21       Impact factor: 6.860

10.  Efficacy of phosphatidylinositol-3 kinase inhibitors in a primary mouse model of undifferentiated pleomorphic sarcoma.

Authors:  Suzy Kim; Rebecca D Dodd; Jeffrey K Mito; Yan Ma; Yongbaek Kim; Richard F Riedel; David G Kirsch
Journal:  Sarcoma       Date:  2012-04-29
View more
  12 in total

1.  NF1+/- Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response.

Authors:  Rebecca D Dodd; Chang-Lung Lee; Tess Overton; Wesley Huang; William C Eward; Lixia Luo; Yan Ma; Davis R Ingram; Keila E Torres; Diana M Cardona; Alexander J Lazar; David G Kirsch
Journal:  Cancer Res       Date:  2017-06-23       Impact factor: 12.701

2.  Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.

Authors:  Lydia Lartigue; Candice Merle; Pauline Lagarde; Lucile Delespaul; Tom Lesluyes; Sophie Le Guellec; Gaelle Pérot; Laura Leroy; Jean-Michel Coindre; Frédéric Chibon
Journal:  Oncogene       Date:  2020-04-02       Impact factor: 9.867

3.  Injury promotes sarcoma development in a genetically and temporally restricted manner.

Authors:  David Van Mater; Eric Xu; Anupama Reddy; Leonor Añó; Mohit Sachdeva; Wesley Huang; Nerissa Williams; Yan Ma; Cassandra Love; Lanie Happ; Sandeep Dave; David G Kirsch
Journal:  JCI Insight       Date:  2018-10-18

4.  A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.

Authors:  Marisa R Buchakjian; Nicole M Merritt; Devon L Moose; Adam J Dupuy; Munir R Tanas; Michael D Henry
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

5.  Distinct Tumor Microenvironments Are a Defining Feature of Strain-Specific CRISPR/Cas9-Induced MPNSTs.

Authors:  Amanda Scherer; Victoria R Stephens; Gavin R McGivney; Wade R Gutierrez; Emily A Laverty; Vickie Knepper-Adrian; Rebecca D Dodd
Journal:  Genes (Basel)       Date:  2020-05-23       Impact factor: 4.096

Review 6.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

7.  Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models.

Authors:  Wade R Gutierrez; Amanda Scherer; Gavin R McGivney; Qierra R Brockman; Vickie Knepper-Adrian; Emily A Laverty; Grace A Roughton; Rebecca D Dodd
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

8.  Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in Pten-deleted Mouse Models of Sarcoma.

Authors:  Rebecca D Dodd; Amanda Scherer; Wesley Huang; Gavin R McGivney; Wade R Gutierrez; Emily A Laverty; Kathleen A Ashcraft; Victoria R Stephens; Parisa Yousefpour; Soumen Saha; Vickie Knepper-Adrian; Warren Floyd; Mark Chen; Yan Ma; Eric M Mastria; Diana M Cardona; William C Eward; Ashutosh Chilkoti; David G Kirsch
Journal:  Clin Cancer Res       Date:  2020-07-27       Impact factor: 12.531

9.  Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.

Authors:  Ariel E Marciscano; Joshua M Walker; Heather M McGee; Michelle M Kim; Charles A Kunos; Arta M Monjazeb; Stephen L Shiao; Phuoc T Tran; Mansoor M Ahmed
Journal:  J Immunother Cancer       Date:  2018-01-29       Impact factor: 13.751

10.  Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas.

Authors:  Kyle M Schachtschneider; Yingkai Liu; Suvi Mäkeläinen; Ole Madsen; Laurie A Rund; Martien A M Groenen; Lawrence B Schook
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.